Discussing the Sunshine Act
October 23, 2012 | ARCHIVE NOW AVAILABLE!
Attention pharmaceutical, biotechnology, medical device and medical supply companies!
Are you ready to report physician payments to the Federal Government?
While no one will argue that transparency in an industry is a bad thing, many will be faced with the challenges that come with such a far-reaching legislation. Full implementation of this legislation is on the way. Before you know it, March 23, 2013 the date of implementation, will be here.
Are you prepared?
This webinar will address the following issues:
· Disclosure demands of the Act and what they entail
· How the new requirements will affect aggregate spend reporting
· How companies are preparing to meet the terms of the new Act
· Best practices to ensure that spending is accurately accounted for under the Act
Konstantinos Papandrikos, Director, Transparency Operations, US Medical Affairs,SANOFI US
Gus Papandrikos is a well-rounded management professional with extensive pharmaceutical industry experience. He currently is a Director within the Medical Affairs group of Sanofi, responsible for Aggregate Spend reporting across the Sanofi group of companies. As the Director of Transparency operations he is responsible for the development, validation and certification of all the various reports. In addition, Gus was responsible for the development of the Aggregate Spend data collection process for Sanofi. Gus holds a BA in Accounting from Pace University and an MBA in Pharmaceutical Management from Rutgers Business School.
|Date: October 23, 2012
Time: ARCHIVE AVAILABLE!
|Professionals from pharmaceutical, biotechnology and medical device companies with responsibilities and interests in the following areas:
- Aggregate Spend
- Law Firms
- Regulatory Compliance
- Medical Affairs
- Commercial Operations
- Legal & Regulatory Affairs
- Government Affairs
- Clinical Operations
- Business Analysis & Development
- Corporate Compliance
- State Reporting
Terms and Conditions
Registration provides individual access to the live webinar and/or event recording. If a webinar is postponed due to unforeseen circumstances, the registrant is entitled to attend the rescheduled webinar or to receive a credit for a future webinar
Copyright 2012 Xtalks Ecademy | Part of Honeycomb Worldwide Inc